top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato A4GALT
alpha-galactosidase A
animal models
astrogliosis
autophagy
axon guidance
biomarkers
bone involvement
cathepsin D
chloroquine
clathrin
Dkk1
dried blood spot
endocytic pathways
endocytosis
enzyme replacement therapy
exosomes
experimental therapies
Fabry disease
GAA biomarker
Gaucher disease
Gaucher Disease
gene therapy
GLA gene
globotriaosyl-sphingosine (lysoGb3)
globotriaosylceramide (Gb3)
globotriaosylsphingosine
glycogen
hematopoietic stem cell transplantations
Hurler syndrome
IGF2R/M6P
iPSC
Krabbe disease
lyso-Gb3
lysosomal diseases
lysosomal storage disorder
lysosomal storage disorders
lysosomal targeting
lysosomal α-glucosidase
lysosome
lysosomes
MIP-1β
mucolipidosis II
mucopolysaccharidosis IIIB
mucopolysaccharidosis type I
muscle
NAGLU
neurodegenerative disease
neuronal circuit
neuronopathy
newborn screening
Osteoimmunology
Osteopontin
Parkinson disease
pharmacological chaperone therapy
pharmacological chaperones
Pompe disease
precision medicine
psychosine
quantitative proteomics
RANK/RANKL
rhGAA
satellite cells
second tier test
sortilin
substrate reduction therapy
tandem mass spectrometry
TGF-beta
Twitcher mouse
variant interpretation
viral vectors
visual cortex
visual system
Wnt/β-catenin
Wnt3a
α-galactosidase A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Newborn Screening for Pompe Disease
Newborn Screening for Pompe Disease
Autore Hwu Wuh-Liang
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (146 p.)
Soggetto topico Technology: general issues
Soggetto non controllato acid α-glucosidase
alpha glucosidase
c.-32-13T&
California
cross-reactive immunologic material
diagnosis
dried blood spots
enzyme replacement therapy
follow-up
G
GAA sequencing
genotype-phenotype correlation
gt
immune modulation therapy
infantile onset Pompe disease
infantile-onset
infantile-onset Pompe disease
late onset Pompe disease
late-onset
lysosomal storage diseases
n/a
new disorders implementation
newborn screening
next generation sequencing
patient perspective
Pompe disease
Pompe disease diagnostics testing
presymptomatic
pseudodeficiency
treatment and follow-up
variant cut-off
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557494603321
Hwu Wuh-Liang  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui